Quick Recap
On October 18, 2022 I published an article on Seeking Alpha that covered the stock selection methodology used by the Dow Jones US Dividend 100 Index, the underlying index for Schwab's U.S. Dividend Equity Fund (SCHD). In that article I proposed a theory, to leverage this stock selection process and apply it to the Dividend Aristocrat universe of stocks. On November 1st, 2022, I launched two mock portfolios doing just that, one is an exact replication of stock selection process and the other has a slight twist that I will get to a little bit later.
Both portfolios were built using the criteria laid out in the original article. A total of 30 dividend aristocrats were chosen for each portfolio based on their ranking using the 4 factor stock selection process for the Dow Jones US Dividend 100 Index. The asset allocation was generated using a float adjusted market capitalization, with the maximum allocation capped at 6.67% (twice the equal weight allocation). Initially I intended to launch these portfolios on January 1st, 2023, but given that NOBL, the most popular Dividend Aristocrat ETF, was launched in November of 2013, I decided to launch my portfolios in November as well. Both portfolios will reinvest all dividends back into the issuing stock based on the market open price for the day following the dividend payment, and the asset allocation will remain unchanged for 1 full year. On November 1st, 2023, I will re-run the stock selection process for each portfolio and re-allocate based on the results. The intention is to see whether there is any merit to such a stock selection strategy, both portfolios will be measured against NOBL and SCHD to see if they can generate superior total returns. I will also be tracking the dividend income each portfolio generates to provide additional color on yield and growth measures. Each portfolio was funded with $10,000 of hypothetical money and no further contributions will be made.
Here are the results for both portfolios thus far.
First Portfolio - Exact Replication
This portfolio followed the exact criteria used by the Dow Jones US Dividend 100 Index. The criteria were.
- Free Cash Flow to Total Debt Ratio
- Return on Equity
- Forward Dividend Yield
- 5 Year Dividend Growth Rate
Here is a snapshot of the portfolio as of May 16th, 2023.
Symbol Shares Market Value Cost Gain/Loss % Gain/Loss ABBV 4.639688 664.82 667.00 -2.18 -0.33% ABT 6.758996 739.37 667.00 72.37 10.85% JNJ 3.884836 619.01 667.00 -47.99 -7.19% CVX 3.692519 566.84 667.00 -100.16 -15.02% PG 5.014733 780.99 667.00 113.99 17.09% PEP 3.733277 722.13 667.00 55.13 8.27% XOM 6.039493 619.17 667.00 -47.83 -7.17% KO 11.271584 712.59 667.00 45.59 6.84% MDT 6.162425 547.84 530.00 17.84 3.37% CAT 2.224665 460.95 484.00 -23.05 -4.76% ADP 1.89823 403.07 455.00 -51.93 -11.41% TGT 2.174966 341.27 357.00 -15.73 -4.41% MMM 2.557504 250.66 316.00 -65.34 -20.68% GD 1.110402 230.51 275.00 -44.49 -16.18% ITW 1.288928 291.30 274.00 17.30 6.31% CL 3.692612 298.25 269.00 29.25 10.87% APD 1.039861 286.58 260.00 26.58 10.22% SYY 2.335631 171.48 197.00 -25.52 -12.95% KMB 1.544821 223.47 189.00 34.47 18.24% AFL 2.818758 183.67 181.00 2.67 1.48% CTAS 0.389106 181.31 166.00 15.31 9.22% NUE 1.215656 166.28 163.00 3.28 2.01% TROW 1.058497 110.19 112.00 -1.81 -1.62% WST 0.378738 134.29 87.00 47.29 54.35% CLX 0.563117 95.17 81.00 14.17 17.50% EXPD 0.746863 83.14 73.00 10.14 13.89% CINF 0.695393 70.80 71.00 -0.20 -0.27% HRL 1.330402 51.93 61.00 -9.07 -14.88% BEN 1.390771 33.41 32.00 1.41 4.39% AOS 0.565752 38.02 31.00 7.02 22.66% Total 10,078.51 10,000.00 78.51 0.79% NOBL 113.675862 10,291.08 10,000.00 291.08 2.91% SCHD 136.675053 9,455.18 10,000.00 -544.82 -5.45%
As you can see the portfolio is performing better than SCHD but still trailing NOBL, with some components seeing more favorable returns than others. The portfolio return has fallen since last month's update and the gap to NOBL has widened. SCHD has performed very poorly during the past few weeks and has fallen quite a lot compared to my portfolio and NOBL. The best selections thus far have been.
- Procter & Gamble (PG) +$113.99 +17.09%
- Abbott Laboratories (ABT) +$72.37 +10.85%
- Pepsi (PEP) +$55.13 +8.27%
- West Pharma (WST) +$47.29 +54.35%
- Coca-Cola (KO) +$45.59 +6.84%
Since inception the portfolio is up 0.79% compared to 2.91% for NOBL and -5.45% for SCHD. This means the portfolio is trailing NOBL by 2.12% but beating SCHD by 6.24%.
Here is a breakdown of the dividend income thus far as of May 16th, 2023.
LFDAS NOBL SCHD MONTH 2022 2023 MONTH 2022 2023 MONTH 2022 2023 January 16.20 January January February 23.95 February February March 32.89 March 40.07 March 80.85 April 21.50 April April May 21.83 May May June June June July July July August August August September September September October October October November 0.07 November November December 29.11 December 67.54 December 94.49 TOTAL 29.18 116.37 TOTAL 67.54 40.07 TOTAL 94.49 80.85 LIFETIME 145.55 LIFETIME 107.61 LIFETIME 175.34
My portfolio did not capture most of the dividends from November and missed out on October income as well. Therefore this initial dividend income comparison is not really apples to apples. The portfolio currently has generated more dividend income than NOBL but trails SCHD. Given that SCHD has a higher dividend yield its unlikely the portfolio will ever generate more dividend income than the ETF.
As of right now my portfolio has a dividend yield of 2.91% compared to 1.93% for NOBL and 3.82% for SCHD.
Since inception the portfolio has drifted away from its starting allocation by 9.42%, which is an increase of nearly 2 percent from the absolute drift a month ago (7.64%). The table below shows the absolute drift for each individual position. I imagine that after 12 months the total drift could be much higher. There are two schools of thought on rebalancing a portfolio to its target allocation. On the one hand you can forego rebalancing and let your winners run, on the other hand you can capture short-term gains and reallocate them to worse performing positions in the hope that they will perform better down the road. I have opted to forego rebalancing this portfolio on a fixed schedule or at a specific drift target. The portfolio will be rebalanced after the first full year comes to an end and new aristocrats are selected using the original stock selection method.
Symbol Starting Allocation Current Allocation Drift ABBV 6.67% 6.60% 0.07% ABT 6.67% 7.34% 0.67% JNJ 6.67% 6.14% 0.53% CVX 6.67% 5.62% 1.05% PG 6.67% 7.75% 1.08% PEP 6.67% 7.17% 0.50% XOM 6.67% 6.14% 0.53% KO 6.67% 7.07% 0.40% MDT 5.30% 5.44% 0.14% CAT 4.84% 4.57% 0.27% ADP 4.55% 4.00% 0.55% TGT 3.57% 3.39% 0.18% MMM 3.16% 2.49% 0.67% GD 2.75% 2.29% 0.46% ITW 2.74% 2.89% 0.15% CL 2.69% 2.96% 0.27% APD 2.60% 2.84% 0.24% SYY 1.97% 1.70% 0.27% KMB 1.89% 2.22% 0.33% AFL 1.81% 1.82% 0.01% CTAS 1.66% 1.80% 0.14% NUE 1.63% 1.65% 0.02% TROW 1.12% 1.09% 0.03% WST 0.87% 1.33% 0.46% CLX 0.81% 0.94% 0.13% EXPD 0.73% 0.82% 0.09% CINF 0.71% 0.70% 0.01% HRL 0.61% 0.52% 0.09% BEN 0.32% 0.33% 0.01% AOS 0.31% 0.38% 0.07% Total 9.42%
Second Portfolio - My Modification
This portfolio modified the criteria used by the Dow Jones US Dividend 100 Index, replacing one of the factors. The criteria use was:
- Free Cash Flow to Total Debt Ratio
- Return on Capital
- Forward Dividend Yield
- 5 Year Dividend Growth Rate
The one factor that was changed was the return on equity, and it was replaced with the return on capital. I personally like this metric better as I think it does a better job of measuring profitability.
Here is a snapshot of the portfolio as of May 16th, 2023.
Symbol Shares Market Value Cost Gain/Loss % Gain/Loss Price Dividend Yield ABBV 4.639688 664.82 667.00 -2.18 -0.33% 143.29 5.92 4.13% ABT 6.758996 739.37 667.00 72.37 10.85% 109.39 2.04 1.86% CVX 3.692519 566.84 667.00 -100.16 -15.02% 153.51 6.04 3.93% XOM 6.039493 619.17 667.00 -47.83 -7.17% 102.52 3.64 3.55% JNJ 3.884836 619.01 667.00 -47.99 -7.19% 159.34 4.76 2.99% MCD 2.464781 725.02 667.00 58.02 8.70% 294.15 6.08 2.07% PG 5.014733 780.99 667.00 113.99 17.09% 155.74 3.76 2.41% LIN 2.199783 804.90 664.00 140.90 21.22% 365.90 5.10 1.39% LOW 2.780197 553.87 545.00 8.87 1.63% 199.22 4.20 2.11% CAT 2.164918 448.57 471.00 -22.43 -4.76% 207.20 4.80 2.32% SPGI 1.455456 522.00 471.00 51.00 10.83% 358.65 3.60 1.00% ADP 1.848185 392.44 443.00 -50.56 -11.41% 212.34 5.00 2.35% TGT 2.120117 332.67 348.00 -15.33 -4.41% 156.91 4.32 2.75% MMM 2.492842 244.32 308.00 -63.68 -20.67% 98.01 6.00 6.12% GD 1.078066 223.80 267.00 -43.20 -16.18% 207.59 5.28 2.54% ITW 1.251284 282.79 266.00 16.79 6.31% 226.00 5.24 2.32% APD 1.011843 278.85 253.00 25.85 10.22% 275.59 7.00 2.54% AFL 2.756469 179.61 177.00 2.61 1.48% 65.16 1.68 2.58% CTAS 0.386181 179.94 161.00 18.94 11.77% 465.96 4.60 0.99% NUE 1.18576 162.19 159.00 3.19 2.01% 136.78 2.04 1.49% TROW 1.030122 107.24 109.00 -1.76 -1.62% 104.10 4.88 4.69% GWW 0.185934 123.51 109.00 14.51 13.31% 664.26 7.44 1.12% GPC 0.611942 101.31 108.00 -6.69 -6.19% 165.56 3.80 2.30% BF.B 1.559613 98.27 106.00 -7.73 -7.29% 63.01 0.82 1.30% CAH 1.186036 101.76 89.00 12.76 14.34% 85.80 2.00 2.33% WST 0.370048 131.20 85.00 46.20 54.36% 354.56 0.76 0.21% EXPD 0.726343 80.86 71.00 9.86 13.88% 111.32 1.38 1.24% HRL 1.308874 51.09 60.00 -8.91 -14.86% 39.03 1.10 2.82% BEN 1.347499 32.37 31.00 1.37 4.41% 24.02 1.20 5.00% AOS 0.547367 36.79 30.00 6.79 22.63% 67.21 1.20 1.79% Total 10,185.57 10,000.00 185.57 1.86% 2.60% NOBL 113.675862 10,291.08 10,000.00 291.08 2.91% 90.53 1.75 1.93% SCHD 136.675053 9,455.18 10,000.00 -544.82 -5.45% 69.18 2.64 3.82%
As you can see the modified portfolio is thus far performing better than the first portfolio and both benchmarks. The best selections thus far have been.
- Linde plc (LIN) +$140.90 +21.22%
- Procter & Gamble +$113.99 +17.09%
- Abbott Laboratories +$72.37 +10.85%
- McDonald's (MCD) +$58.02 +8.70%
- S&P Global (SPGI) +$51.00 +10.83%
Since inception the portfolio is up 1.86% compared to 2.91% for NOBL and -5.45% for SCHD. After a tough few weeks the portfolio trails NOBL by 1.05% but remains ahead of SCHD by 7.31%.
Comparing both portfolios the second strategy is 1.07% better than the first.
Here is a breakdown of the dividend income by month as of May 16th, 2023.
LFDAM NOBL SCHD MONTH 2022 2023 MONTH 2022 2023 MONTH 2022 2023 January 5.75 January January February 24.29 February February March 32.27 March 40.07 March 80.85 April 5.81 April April May 22.18 May May June June June July July July August August August September September September October October October November 0.07 November November December 31.78 December 67.54 December 94.49 TOTAL 31.85 90.30 TOTAL 67.54 40.07 TOTAL 94.49 80.85 LIFETIME 122.15 LIFETIME 107.61 LIFETIME 175.34
This portfolio got off to a better start compared to the first portfolio, generating more dividend income in partial 2022 ($31.85 vs. $29.18). But since it has a lower dividend yield it was only a matter of time before the first portfolio moved into the lead.
This portfolio does have a dividend yield that is higher than NOBL so it should outpace the ETF in dividend income in the long run. It is also more growth oriented and should bridge the gap in dividend income with the first portfolio over a very long time frame.
What will be interesting to see is which portfolio will achieve a better dividend growth rate and how dividend reinvestment will differ between the two portfolios. Thus far the portfolio is slightly ahead of NOBL in lifetime dividend income but considerably behind SCHD.
This portfolio also trails the first portfolio in terms of dividend income by about $23.
Since inception the portfolio has drifted away from its starting allocation by 10.04%, which is an increase of exactly 200 bps from a month ago (8.04%). The table below shows the absolute drift for each individual position. This is the first time since inception where this portfolio has a higher absolute drift than the first portfolio. The same rebalancing rules will be applied to this portfolio as to the first portfolio.
Symbol Starting Allocation Current Allocation Drift ABBV 6.67% 6.53% 0.14% ABT 6.67% 7.26% 0.59% CVX 6.67% 5.57% 1.10% XOM 6.67% 6.08% 0.59% JNJ 6.67% 6.08% 0.59% MCD 6.67% 7.12% 0.45% PG 6.67% 7.67% 1.00% LIN 6.64% 7.90% 1.26% LOW 5.45% 5.44% 0.01% CAT 4.71% 4.40% 0.31% SPGI 4.71% 5.12% 0.41% ADP 4.43% 3.85% 0.58% TGT 3.48% 3.27% 0.21% MMM 3.08% 2.40% 0.68% GD 2.67% 2.20% 0.47% ITW 2.66% 2.78% 0.12% APD 2.53% 2.74% 0.21% AFL 1.77% 1.76% 0.01% CTAS 1.61% 1.77% 0.16% NUE 1.59% 1.59% 0.00% TROW 1.09% 1.05% 0.04% GWW 1.09% 1.21% 0.12% GPC 1.08% 0.99% 0.09% BF.B 1.06% 0.96% 0.10% CAH 0.89% 1.00% 0.11% WST 0.85% 1.29% 0.44% EXPD 0.71% 0.79% 0.08% HRL 0.60% 0.50% 0.10% BEN 0.31% 0.32% 0.01% AOS 0.30% 0.36% 0.06% Total 10.04%
Portfolio Differences
Now that we have taken a closer look at each portfolio let's go over the differences between them and what impact these differences have made.
First up let's go over the 8 unique aristocrats found in each portfolio. The first portfolio owns the following unique aristocrats.
TICKER % GAIN STARTING ALLOCATION IMPACT ON PORTFOLIO PEP 8.27% 6.67% 0.55% KO 6.84% 6.67% 0.46% MDT 3.37% 5.30% 0.18% CL 10.87% 2.69% 0.29% SYY -12.95% 1.97% -0.26% KMB 18.24% 1.89% 0.34% CLX 17.50% 0.81% 0.14% CINF -0.27% 0.71% 0.00% 6.48% 26.71% 1.71%
On average these 8 aristocrats are up 6.48% since November 1st. Their combined starting allocation in the portfolio was 26.71% and as a result their impact on the overall portfolio return thus far has been a gain of 1.71%. Overall the return of these 8 holdings has improved from a month ago when it was 1.13%
Here are the 8 unique aristocrats in the second portfolio.
TICKER % GAIN STARTING ALLOCATION IMPACT ON PORTFOLIO MCD 8.70% 6.67% 0.58% LIN 21.22% 6.64% 1.41% LOW 1.63% 5.45% 0.09% SPGI 10.83% 4.71% 0.51% GWW 13.31% 1.09% 0.15% GPC -6.19% 1.08% -0.07% BF.B -7.29% 1.06% -0.08% CAH 14.34% 0.89% 0.13% 7.07% 27.59% 2.72%
We can clearly see these 8 aristocrats on average have performed better than the 8 unique aristocrats in the first portfolio. They also made up a slightly larger initial allocation of the portfolio and as a result played a more significant role on the overall return, +2.72%. However, since last month's update the overall return has declined from 2.83% to 2.72%, while the first portfolio's unique holdings have seen their average return improve.
I believe these 16 aristocrats will be the main drivers of the long term difference between these two portfolios. Of course there are more allocation differences between the common aristocrats shared by both portfolios and that will play a role as well.
Dividend Increases
Since the last update 5 more dividend aristocrats have announced higher dividend rates, bringing the running total to 20 since inception. The first portfolio, LFDAS, has seen 15 increases while the second portfolio, LFDAM, has seen 14. The average dividend growth rate for LFDAS has been 4.46%, while the average dividend growth rate for LFDAM has been a slightly better 4.85%.
Dividend Schedule Portfolio Ex Date Pay Date Dividend Rate LFDAS LFDAM AFL Both 11/15/2022 12/1/2022 0.4000 AFL Both 2/15/23 3/2/2023 0.4200 5.00% 5.00% APD Both 12/30/2022 2/13/2023 1.6200 APD Both 3/31/23 5/8/23 1.7500 8.02% 8.02% CAH LFDAM 3/31/23 4/15/23 0.4950 CAH LFDAM 6/30/23 7/15/23 0.5000 1.01% CINF LFDAS 12/15/2022 1/13/2023 0.6900 CINF LFDAS 3/16/23 4/14/23 0.7500 8.70% CL LFDAS 1/20/2023 2/14/2023 0.4700 CL LFDAS 4/20/23 5/15/23 0.4800 2.13% CVX Both 11/17/2022 12/12/2022 1.4200 CVX Both 2/15/23 3/10/2023 1.5100 6.34% 6.34% EXPD Both 11/30/2022 12/15/2022 0.6700 EXPD Both 5/31/23 6/15/2023 0.6900 2.99% 2.99% GD Both 1/19/2023 2/10/2023 1.2600 GD Both 4/13/23 5/12/23 1.3200 4.76% 4.76% GPC LFDAM 12/1/2022 1/3/2023 0.8950 GPC LFDAM 3/2/23 4/3/23 0.9500 6.15% GWW LFDAM 2/10/23 3/1/2023 1.7200 GWW LFDAM 5/5/23 6/1/23 1.8600 8.14% JNJ Both 2/17/23 3/7/2023 1.1300 JNJ Both 5/22/23 6/6/23 1.1900 5.31% 5.31% KMB LFDAS 12/8/2022 1/4/2023 1.1600 KMB LFDAS 3/9/23 4/4/23 1.1800 1.72% KO LFDAS 11/30/2022 12/15/2022 0.4400 KO LFDAS 3/16/23 4/3/2023 0.4600 4.55% LIN LFDAM 12/1/2022 12/16/2022 1.1700 LIN LFDAM 3/13/23 3/28/2023 1.2750 8.97% MMM Both 11/17/2022 12/12/2022 1.4900 MMM Both 2/16/23 3/12/2023 1.5000 0.67% 0.67% PEP LFDAS 3/2/23 3/31/23 1.1500 PEP LFDAS 6/1/23 6/30/23 1.2650 10.00% PG Both 1/19/2023 2/15/2023 0.9125 PG Both 4/20/23 5/15/23 0.9400 3.01% 3.01% SPGI LFDAM 11/25/2022 12/12/2022 0.8500 SPGI LFDAM 2/23/23 3/10/2023 0.9000 5.88% SYY LFDAS 4/5/23 4/28/23 0.4900 SYY LFDAS 7/6/23 7/28/23 0.5000 2.04% TROW Both 12/15/2022 12/29/2022 1.2000 TROW Both 3/14/23 3/30/23 1.2200 1.67% 1.67% AVERAGE 4.46% 4.85%
Top 30 Dividend Aristocrats Today
Since it has been more than 6 months since I originally selected these lists I felt it would be interesting to run the same analysis once more and see which aristocrats rank the best today. I ran the second screener only with the return on capital factor instead of the original return on equity. Therefore this new list is more of a comparison to LFDAM than LFDAS. Here are the top 30 selected aristocrats along with their metrics.
Symbol FCF/Total Debt Yield FWD Div Growth 5Y ROC TROW 415.34% 4.59% 14.87% 12.53% ADP 115.21% 2.33% 13.80% 36.79% ABBV 38.79% 4.04% 14.53% 15.83% AOS 131.84% 1.76% 13.02% 19.15% CVX 210.08% 3.84% 5.76% 14.86% EXPD 434.51% 1.22% 9.79% 25.68% XOM 189.04% 3.46% 2.89% 20.39% ITW 32.85% 2.29% 11.49% 21.30% LOW 22.55% 2.08% 20.69% 31.55% CTAS 54.67% 0.98% 23.21% 16.79% JNJ 38.69% 2.98% 6.11% 14.04% NUE 132.02% 1.45% 5.92% 22.85% CLX 35.14% 2.83% 6.29% 13.15% CHRW 85.38% 2.44% 4.97% 17.11% KMB 36.15% 3.28% 3.57% 17.46% ABT 50.86% 1.86% 12.45% 8.71% NDSN 45.21% 1.20% 16.02% 12.14% CAH 105.05% 2.35% 1.40% 27.61% GWW 52.66% 1.11% 6.19% 27.22% BEN 35.93% 4.90% 6.53% 6.07% PG 41.59% 2.41% 5.73% 14.33% MMM 34.56% 5.97% 4.09% 9.63% PEP 25.36% 2.60% 7.39% 12.94% AFL 29.28% 2.54% 11.30% 8.59% CINF 235.08% 2.88% 6.79% -0.10% WST 226.11% 0.21% 6.40% 16.14% TGT 20.98% 2.69% 11.74% 8.29% GD 33.67% 2.51% 8.13% 8.85% SYY 21.10% 2.69% 7.27% 12.65% CAT 24.37% 2.27% 9.00% 12.64%
Comparing this list to LFDAM there are 7 changes. The following stocks have dropped off: Air Products and Chemicals (APD), Brown-Forman (BF.B), Genuine Parts Company (GPC), Hormel (HRL), Linde plc (LIN), McDonald's (MCD) and S&P Global (SPGI). They are replaced by: C.H. Robinson Worldwide (CHRW), Cincinnati Financial (CINF), Clorox (CLX), Kimberly-Clark (KMB), Nordson (NDSN), Pepsi and Sysco (SYY).
Comparing this list to LFDAS there are only 5 changes. The following stocks drop off: Air Products and Chemicals (APD), Colgate Palmolive (CL), Hormel (HRL), Coca-Cola and Medtronic (MDT). They are replaced by: Cardinal Health (CAH), C.H. Robinson Worldwide (CHRW), Grainger (GWW) and Lowe's (LOW).
C.H. Robinson Worldwide and Nordson both were not on the dividend aristocrat list when I made my initial selections.
Future
The long-term goal is to determine whether this stock selection strategy has merit. This will be measured by whether or not either of these portfolios can achieve and sustain long term alpha over NOBL. I am also comparing the results to SCHD but since this ETF uses a different universe of stocks it isn't really a fair benchmark in this test. I would like to see both portfolios outpace NOBL and remain competitive when measured against SCHD. I'll be providing updates throughout the year and when the time comes to select new constituents for each portfolio.
This article was written by
Dividend Yield Theorist
5.9K
Follower
s
I have a masters degree in Analytics from Northwestern University and a bachelors degree in Accounting. I have worked in the investment arena for over 10 years starting as an analyst and working my way up to a management role. Dividend investing is a personal hobby and I look forward to sharing my thoughts with the Seeking Alpha community. In addition to being a contributor here on Seeking Alpha I publish informative videos on YouTube using the following channel https://www.youtube.com/channel/UCVh4UdktgeaPx8Ndm-j72xg
Analyst’s Disclosure: I/we have a beneficial long position in the shares of ABBV, CTAS, EXPD, HRL, JNJ, LOW, PEP, PG, TROW, WST either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.